Verona Pharma Plc Ord 5P is listed on the London Stock Exchange trading with ticker code VRP.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £4,055m, with approximately 105m shares in issue. Over the last year, Verona Pharma share price has been traded in a range of 67.5, hitting a high of 106.00, and a low of 38.50.
Verona Pharma Plc Ord 0.1P, officially known as Verona Pharma Plc Ord 5P was formed in February of 2005, making the company fourteen years old. The company filed its latest accounts on 31st December 2014. Verona Pharma Plc Ord 0.1P currently has 6 directors, and has had 9 previous directors over the last 14 years. In the last set of accounts produced by Uhy Hacker Young, the company showed 284 thousand paid in salaries to the 11 staff (average wage of 26 thousand), with the directors receiving an average 125 thousand each. In the accounts filed in 2014, the company paid 0 in dividends. These accounts also showed Verona Pharma Plc Ord 0.1P to have a net worth of 10.75 million, with 9.97 million held in cash.
Verona Pharma is in the Medicine and Biotech Research sector.
Verona Pharma is in the AIM 350 index.
|Allergy Thera. (AGY.L)|
|Shares in Issue||105m|
|52 Week High||106.00|
|52 Week Low||38.50|